Table 1.
Biomedical Characteristics and Scores for Psychosocial Measures at Baseline.
Table 1A. Biomedical Characteristics (N = 61). | ||
---|---|---|
Sex (% male) | 52 | |
Age (years) | 12.7 ± 2.9 | |
Diabetes duration (years) | 6.3 ± 3.8 | |
z-BMI (SDS) | 0.5 ± 1.0 | |
Insulin dose (U/kg/day) | 0.9 ± 0.3 | |
Basal dose (% of total daily dose) | 41 ± 7 | |
Insulin regimen (% pump users) | 80 | |
Blood glucose monitoring (times/day) | 7.0 ± 2.6 | |
Missing insulin doses (% yes) | 38 | |
A1c (%) | 7.9 ± 0.9 | |
A1c <7.5% (ADA target) (%) | 33 | |
CGM use (hours/week, mean ± SD) | 128.7 ± 18.9 | |
CGM use (hours/week, median) | 134.3 | |
Table 1B. Psychosocial Characteristics. | ||
Youth survey scores | Parent survey scores | |
Parent involvement | 46.9 ± 15.9 | 57.4 ± 17.6 |
Diabetes-specific family conflict | 13.0 ± 18.0 | 10.6 ± 9.4 |
Fear of hypoglycemia | 25.1 ± 17.5 | 39.8 ± 16.9 |
Depressive symptoms | 9.1 ± 8.2 | 9.0 ± 8.0 |
State anxiety | 28.1 ± 3.9 | 31.1 ± 9.2 |
Trait anxiety | 27.9 ± 5.4 | 34.0 ± 8.5 |
Diabetes burden | 25.5 ± 19.1 | 41.4 ± 19.9 |
Youth QoL (generic) | 86.5 ± 11.1 | 82.5 ± 11.6 |
Youth QoL (diabetes-specific) | 79.9 ± 10.7 | 75.7 ± 11.2 |
Data are mean ± SD or %. A1c, hemoglobin A1c; CGM, continuous glucose monitoring; QoL, quality of life; SDS, SD score; z-BMI, body mass index z-score.